Pulmonary function tests in obese people candidate to bariatric surgery
C Guimarães1, M V Martins, J Moutinho Dos Santos
1Serviço de Pneumologia, Centro Hospitalar de Coimbra-EPE, Coimbra, Portugal. catarina.guimaraes@yahoo.com
Revista Portuguesa De Pneumologia
|March 10, 2012
Summary
Morbid obesity significantly impairs respiratory function, often causing restrictive lung disorders. Bariatric surgery improves pulmonary function tests (PFTs) by reducing body mass index (BMI) and resolving these restrictions.
Area of Science:
- Pulmonary Medicine
- Bariatric Surgery
- Public Health
Background:
- Obesity is a major global health issue impacting multiple physiological systems.
- Altered mechanics of the respiratory system (lungs, chest wall, diaphragm) in obesity affect respiratory function.
- Limited data exists in Portugal regarding obesity's impact on pulmonary function.
Purpose of the Study:
- To characterize respiratory function in morbidly obese patients.
- To evaluate the effect of weight loss post-bariatric surgery on pulmonary function tests (PFTs).
Main Methods:
- Retrospective study of 36 morbidly obese patients undergoing bariatric surgery.
- Clinical and functional evaluations, including comprehensive PFTs (spirometry, lung volumes, DLCO, respiratory pressures, arterial blood gases), before and after surgery.
- Analysis of changes in pulmonary function parameters correlated with body mass index (BMI) reduction.
Main Results:
- Pre-surgery: Almost all patients exhibited respiratory changes, with 34 showing decreased functional residual capacity (FRC), including 6 with restrictive syndrome.
- Post-surgery: Significant improvement in most PFTs and resolution of restrictive disorders occurred after weight loss (BMI decreased from 49.7 to 34 kg/m²).
- A negative correlation was found between BMI reduction and increased FRC (r = -0.371; p = 0.028), indicating improved lung volumes with weight loss.
Conclusions:
- Obesity is strongly associated with pulmonary restriction.
- Bariatric surgery leads to significant improvements in pulmonary function tests in morbidly obese patients.
- Weight loss following bariatric surgery positively impacts respiratory mechanics and function.
Related Concept Videos
01:25Pulmonary Function Tests
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.